… ways of treating the condition are needed. The focus of this review is the treatment of
cutaneous GvHD through phototherapy. Of the six acute and ten chronic cutaneous GvHD case …

… We retrospectively reviewed all patients with chronic cutaneous GVHD treated with
phototherapy from March 2011 to October 2014. The information collected included age, sex, …

… phototherapy may be considered a valuable treatment option for selected patients with
cutaneous … ultraviolet phototherapy. Patients with severe systemic involvement, regardless of the …

… Skin lesions showed complete clearance in 7 out of 10 patients within 3 to 5 weeks. 3 … -B
phototherapy is a nonaggressive treatment that may benefit patients with cutaneous GVHD who …

… provides evidence that NB‐UVB phototherapy represents a valid second‐line treatment in
paediatric patients affected by GVHD and refractory to immunosuppressive first‐line treatment. …

… Skin is usually the first and most … graft-versus-host disease (GvHD), and treatment is still a
clinical challenge. Although the need for skin-directed treatments such as physical treatments …

… We report here our experience with UVB phototherapy in patients with cutaneous and … We
have treated three patients with UVB phototherapy for refractory cutaneous cGVHD. Although …

… Standard treatment of cutaneous aGVHD involves the intensification of immunosuppressive
therapy with adequate topical supportive management. In skin-limited disease, phototherapy …

… clinically significant improvement of cutaneous lesions over the … control of cutaneous GVHD
over 6 months of therapy. … UV-B phototherapy for the treatment of sclerotic chronic cutaneous …

… skin diseases. UVA1 as an adjunct to systemic … treatment was found to be safe, and effective
in 10 patients with chronic cutaneous (seven lichenoid and three sclerodermoid) graft-versus…